B4GALNT2 and colorectal cancer: Dramatic loss or down regulation of B4GALNT2 has been shown in colorectal cancer [23], leading to increased formation of the sialyl-Lewis antigens, which have been employed as biomarkers for colorectal cancer [188,511].